29 results
424B3
ONCSQ
ONCOSEC MEDICAL Inc
1 Dec 22
Prospectus supplement
4:56pm
positions at Novartis, Takeda, GlaxoSmithKline, and Pfizer. Dr. Arch’s expertise in basic research and drug development includes chronic liver disease
8-K
hvfp780
29 Apr 22
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
8:00am
8-K
EX-99.1
62n6z3v
29 Apr 22
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
8:00am
424B4
fjaqcn1lx5rauq 2pa
10 Dec 13
Prospectus supplement with pricing info
12:00am
424B3
yk3sm
10 Dec 13
Prospectus supplement
12:00am
424B4
0trz3s m28xyi0
17 Sep 13
Prospectus supplement with pricing info
12:00am
424B4
ncq7duzwer
13 Dec 12
Prospectus supplement with pricing info
12:00am
POS AM
8afd0 a29
31 Oct 12
Prospectus update (post-effective amendment)
12:00am
424B4
r17uum843u
27 Mar 12
Prospectus supplement with pricing info
12:00am